Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.85 EUR | -0.63% | -4.73% | +83.41% |
06-05 | OSE Immuno: positive analysis presented at ATC congress | CF |
05-30 | OSE Immuno: towards an evolution of the Board of Directors | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.41% | 184M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- OSE Immunotherapeutics SA Appoints Nicolas Poirier as Director